Sign in
From clinical trial to clinical setting: what are the observed prescribing behaviors in the United States since the launch of PCSK9 inhibitors?
Journal article   Peer reviewed

From clinical trial to clinical setting: what are the observed prescribing behaviors in the United States since the launch of PCSK9 inhibitors?

Dean Karalis, Susan Boklage, Joseph Elassal, Ameen Ghannam, Rishab Gupta and Usha Mallya
Circulation (New York, N.Y.), Vol.134(19)
08 Nov 2016

Metrics

2 Record Views

Details